Approval · Notice of Compliance 10253 · 2009
CEFA-DRI: Notice of Compliance 10253
Issued June 16, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10253
- Date
- June 16, 2009
- Company
- Wyeth Animal Health, Division Of Wyeth CanadaKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate source of active ingredient
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEFA-DRI | 02173255 | Marketed |
Medicinal ingredients
- CEPHAPIRIN BENZATHINE 300 MG per 10ML